期刊文献+

认知增强药物的伦理问题及对策 被引量:2

Ethical Problems and Countermeasures of Cognitive Enhancement Drugs
下载PDF
导出
摘要 药物认知增强分为传统、胆碱酯酶抑制剂和新型认知增强药物。赞成使用认知增强药物观点的评析内容包括权力与自由、自主性、目的论的主张和消除不平等论,反对观点的评析包括安全性、破坏人的自主性、奋斗价值和破坏社会公正。需先立法以加强监督,通过向公众科普,发挥社会舆论监督的作用。认知增强药物的使用应按照超说明书用药标准管理,先后通过医院药事管理委员会和伦理委员会审查,明确使用者、知情同意、药物管理以及跟踪审查等,确保合理合规。 Cognitive enhancement drugs are divided into traditional cholinesterase inhibitors and new cognitive enhancement drugs.Evaluation and analysis content in favor of the use of cognition enhancement drugs include power and freedom,autonomy,teleological propositions and the elimination of inequality,and the evaluation and analysis content of opposing viewpoints include security,destruction of human autonomy,struggle value and destruction of social justice.It needs to legislate first in order to strengthen supervision,and play the supervision of public opinion through the popular public.The use of cognitive enhancement drugs should be managed according to the standard of off-label drug use,be reviewed by the hospital pharmacy management committee and the ethics committee,and clear the users,informed consent,drug management and tracking review,so as to ensure reasonable compliance.
作者 刘丹 周吉银 曾圣雅 LIU Dan;ZHOU Jiyin;ZENG Shengya(National Drug Clinical Trial Institution,the Second Affiliated Hospital,Army Medical University,Chongqing 400037,China)
出处 《中国医学伦理学》 2018年第12期1544-1548,共5页 Chinese Medical Ethics
基金 2017年陆军军医大学人文社会科学基金:临床科研项目伦理跟踪审查质量建设(2017XRW23)
关键词 认知增强药物 超说明书 药事管理 跟踪审查 Cognitive Enhancement Drugs Off-Label Pharmacy Management Tracking Review
  • 相关文献

参考文献1

二级参考文献37

  • 1Olga A. H. Reneerkens,Kris Rutten,Harry W. M. Steinbusch,Arjan Blokland,Jos Prickaerts.Selective phosphodiesterase inhibitors: a promising target for cognition enhancement[J]. Psychopharmacology . 2009 (1-3)
  • 2Bernard K,Danober L,Thomas JY,et al.Drug Focus:S 18986:Apositive allosteric modulator of AMPA-type glutamate receptors phar-macological profile of a novel cognitive enhancer. CNS NeurosciTher . 2010
  • 3Chen CC,Yang CH,Huang CC,et al.Acute stress impairs hip-pocampal mossy fiber-CA3 long-term potentiation by enhancingcAMP-specific phosphodiesterase 4 activity. Neuropsychopharmacology . 2010
  • 4Rutten K,Donkelaar ELV,Ferrington L,et al.Phosphodiester-ase inhibitors enhance object memory independent of cerebralblood flow and glucose utilization in rats. Neuropsychophar-macology . 2009
  • 5Schmidt CJ.Phosphodiesterase inhibitors as potential cognitionenhancing agents. Current Topics in Medicinal Chemistry . 2010
  • 6Pierre S,Eschenhagen T,Geisslinger G,et al.Capturing adeny-lyl cyclases as potential drug targets. Nature Reviews Drug Discovery . 2009
  • 7Enhancing,not cheating. Nature . 2007
  • 8Gerrard P,Malcolm R.Mechanisms of modafinil:a review of cur-rent research. Neuropsychiatr Dis Treat . 2007
  • 9Yesavage JA,Mumenthaler MS,Taylor JL,et al.Donepezil andflight simulator performance:effects on retention of complex skills. Neurology . 2002
  • 10Repantis D,,Laisney O,Heuser I.Acetylcholinesterase inhibitorsand memantine for neuroenhancement in healthy individuals:asystematic review. Pharmacological Research . 2010

共引文献3

同被引文献41

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部